LRRIQ3
Leucine-rich repeat and IQ domain-containing protein 3
Also known as: LRIQ3_HUMAN, LRRC44, MGC22773
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6PVS8
- Gene
- LRRIQ3
- Ensembl
- ENSG00000162620
- Chromosome
- 1
- Canonical length
- 624 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
No narrative summary is available for LRRIQ3 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
624 residues, UniProt reviewed canonical sequence.
>A6PVS8|LRRIQ3
1 MFHGTVTEEL TSHEEWSHYN ENIREGQKDF VFVKFNGLHL KSMENLQSCI SLRVCIFSNN
61 FITDIHPLQS CIKLIKLDLH GNQIKSLPNT KFWNGLKNLK LLYLHDNGFA KLKNICVLSA
121 CPTLIALTMF DCPVSLKKGY RHVLVNSIWP LKALDHHVIS DEEIIQNWHL PERFKACNHR
181 LFFNFCPALR KGTTYEEEIN NIKHITSKIN AILAHNSPVL IVQRWIRGFL VRKNLSPVFF
241 HKKKQQEKII RGYEAKWIYI TKGYEDKLLK DLFFKPETNI KGKLAYWKHN IYYPVDLKNS
301 SEHRKHVSSI LCELKPKDLG MKSKTSRHLI QKGQESEDEI VDEKLDTSFR ISVFKLPIYT
361 SGSLKNNAVL REKKQHFFPA YPQPIYTTHP KPIIKKDIRL ERSMKEFFAP QRAGMKLRTF
421 SDIDKYYTEQ KKQEYHKEKV RVVAMAQVAR ERVRVAVNEH LNQKKYATQK LIEENKETIQ
481 NSLRQVWQNR FNYLEKARER KALFLKEKSQ KASERLLVQN LNNERTLLTR GLLKIDRLEK
541 NEAVLKEKSL IVKQKLKAEK YRKNLLKEMK KVRSQEIYKR HCEEKFVMDM IAFEKACERL
601 QDAKTKVAIV KTNLDFKVPN GLIKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRRIQ3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- testis: 19 nTPM
- fallopian tube: 2 nTPM
- kidney: 1.9 nTPM
- choroid plexus: 1.7 nTPM
- adipose tissue: 1.5 nTPM
- thyroid gland: 1.4 nTPM
Single-cell type
- late primary spermatocytes: 475 nCPM
- early spermatids: 195 nCPM
- adipocytes: 129 nCPM
- late spermatids: 123 nCPM
- early primary spermatocytes: 122 nCPM
- ependymal cells: 64 nCPM
Immune cell
- memory B-cell: 1.6 nTPM
- T-reg: 1.6 nTPM
- naive CD8 T-cell: 1.3 nTPM
- MAIT T-cell: 1.1 nTPM
- memory CD8 T-cell: 1.1 nTPM
- memory CD4 T-cell: 1 nTPM
Brain region
- choroid plexus: 2.1 nTPM
- midbrain: 1.4 nTPM
- pons: 1.2 nTPM
- medulla oblongata: 1.1 nTPM
- thalamus: 1 nTPM
- white matter: 1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.82
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Leucine-rich repeat
- Leucine-rich repeat domain superfamily
- Leucine-rich repeat and IQ domain-containing protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRRIQ3 as an antibody target. Whether an autoantibody or antibody against LRRIQ3 could matter depends on whether native LRRIQ3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRRIQ3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRRIQ3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...